Azacytidine Plus FLAG for Relapsed or Refractory AML

Clinical trial NCT02275663 · UNKNOWN

Trial details

NCT number: NCT02275663
Sponsor: King Fahad Medical City
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2014-12-01
Primary completion: 2017-10-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.